These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 12054613

  • 1. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors.
    Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, Suenaga M, Abe M, Fukusumi S, Watanabe T, Shintani Y, Yamada T, Hinuma S, Inatomi N, Ohtaki T, Onda H, Fujino M.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):396-402. PubMed ID: 12054613
    [Abstract] [Full Text] [Related]

  • 2. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor.
    Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY.
    J Biol Chem; 2002 May 31; 277(22):19276-80. PubMed ID: 11886876
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Identification of an angiogenic mitogen selective for endocrine gland endothelium.
    LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N.
    Nature; 2001 Aug 30; 412(6850):877-84. PubMed ID: 11528470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
    Ngan ES, Sit FY, Lee K, Miao X, Yuan Z, Wang W, Nicholls JM, Wong KK, Garcia-Barcelo M, Lui VC, Tam PK.
    Clin Cancer Res; 2007 Feb 01; 13(3):868-75. PubMed ID: 17289879
    [Abstract] [Full Text] [Related]

  • 7. The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.
    Pasquali D, Rossi V, Staibano S, De Rosa G, Chieffi P, Prezioso D, Mirone V, Mascolo M, Tramontano D, Bellastella A, Sinisi AA.
    Endocrinology; 2006 Sep 01; 147(9):4245-51. PubMed ID: 16763065
    [Abstract] [Full Text] [Related]

  • 8. Placental expression of EG-VEGF and its receptors PKR1 (prokineticin receptor-1) and PKR2 throughout mouse gestation.
    Hoffmann P, Feige JJ, Alfaidy N.
    Placenta; 2007 Oct 01; 28(10):1049-58. PubMed ID: 17531315
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells.
    Kisliouk T, Levy N, Hurwitz A, Meidan R.
    J Clin Endocrinol Metab; 2003 Aug 01; 88(8):3700-7. PubMed ID: 12915658
    [Abstract] [Full Text] [Related]

  • 13. Molecular cloning and characterization of prokineticin receptors.
    Soga T, Matsumoto Si, Oda T, Saito T, Hiyama H, Takasaki J, Kamohara M, Ohishi T, Matsushime H, Furuichi K.
    Biochim Biophys Acta; 2002 Dec 12; 1579(2-3):173-9. PubMed ID: 12427552
    [Abstract] [Full Text] [Related]

  • 14. Endocrine glands-derived vascular endothelial growth factor protects pancreatic cancer cells from apoptosis via upregulation of the myeloid cell leukemia-1 protein.
    Ren LN, Li QF, Xiao FJ, Yan J, Yang YF, Wang LS, Guo XZ, Wang H.
    Biochem Biophys Res Commun; 2009 Aug 14; 386(1):35-9. PubMed ID: 19523441
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mouse endocrine gland-derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis.
    LeCouter J, Lin R, Frantz G, Zhang Z, Hillan K, Ferrara N.
    Endocrinology; 2003 Jun 14; 144(6):2606-16. PubMed ID: 12746324
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prokineticin-signaling pathway.
    Ngan ES, Tam PK.
    Int J Biochem Cell Biol; 2008 Jun 14; 40(9):1679-84. PubMed ID: 18440852
    [Abstract] [Full Text] [Related]

  • 19. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
    Zhang L, Yang N, Conejo-Garcia JR, Katsaros D, Mohamed-Hadley A, Fracchioli S, Schlienger K, Toll A, Levine B, Rubin SC, Coukos G.
    Clin Cancer Res; 2003 Jan 14; 9(1):264-72. PubMed ID: 12538479
    [Abstract] [Full Text] [Related]

  • 20. Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists.
    Bullock CM, Li JD, Zhou QY.
    Mol Pharmacol; 2004 Mar 14; 65(3):582-8. PubMed ID: 14978236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.